These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

704 related items for PubMed ID: 28131717

  • 1. Aptamer-functionalized hybrid nanoparticle for the treatment of breast cancer.
    Powell D, Chandra S, Dodson K, Shaheen F, Wiltz K, Ireland S, Syed M, Dash S, Wiese T, Mandal T, Kundu A.
    Eur J Pharm Biopharm; 2017 May; 114():108-118. PubMed ID: 28131717
    [Abstract] [Full Text] [Related]

  • 2. Aptamer-functionalized Hybrid Nanoparticles to Enhance the Delivery of Doxorubicin into Breast Cancer Cells by Silencing P-glycoprotein.
    Chandra S, Michael Nguyen H, Wiltz K, Hall N, Chaudhry S, Olverson G, Mandal T, Dash S, Kundu A.
    J Cancer Treatment Diagn; 2020 May; 4(1):1-13. PubMed ID: 32395707
    [Abstract] [Full Text] [Related]

  • 3. Targeted Delivery of Doxorubicin Liposomes for Her-2+ Breast Cancer Treatment.
    Chowdhury N, Chaudhry S, Hall N, Olverson G, Zhang QJ, Mandal T, Dash S, Kundu A.
    AAPS PharmSciTech; 2020 Jul 21; 21(6):202. PubMed ID: 32696338
    [Abstract] [Full Text] [Related]

  • 4. Anti-Mucin1 Aptamer-Conjugated Chitosan Nanoparticles for Targeted Co-Delivery of Docetaxel and IGF-1R siRNA to SKBR3 Metastatic Breast Cancer Cells.
    Jafari R, Majidi Zolbanin N, Majidi J, Atyabi F, Yousefi M, Jadidi-Niaragh F, Aghebati-Maleki L, Shanehbandi D, Soltani Zangbar MS, Rafatpanah H.
    Iran Biomed J; 2019 Jan 21; 23(1):21-33. PubMed ID: 30041514
    [Abstract] [Full Text] [Related]

  • 5. Epithelial cell adhesion molecule aptamer conjugated PEG-PLGA nanopolymersomes for targeted delivery of doxorubicin to human breast adenocarcinoma cell line in vitro.
    Alibolandi M, Ramezani M, Sadeghi F, Abnous K, Hadizadeh F.
    Int J Pharm; 2015 Feb 01; 479(1):241-51. PubMed ID: 25529433
    [Abstract] [Full Text] [Related]

  • 6. Targeted delivery of doxorubicin to breast cancer cells by aptamer functionalized DOTAP/DOPE liposomes.
    Song X, Ren Y, Zhang J, Wang G, Han X, Zheng W, Zhen L.
    Oncol Rep; 2015 Oct 01; 34(4):1953-60. PubMed ID: 26238192
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Aptamer-nanoparticle bioconjugates enhance intracellular delivery of vinorelbine to breast cancer cells.
    Zhou W, Zhou Y, Wu J, Liu Z, Zhao H, Liu J, Ding J.
    J Drug Target; 2014 Jan 01; 22(1):57-66. PubMed ID: 24156476
    [Abstract] [Full Text] [Related]

  • 9. Quick synthesis of a novel combinatorial delivery system of siRNA and doxorubicin for a synergistic anticancer effect.
    Chen M, Wang L, Wang F, Li F, Xia W, Gu H, Chen Y.
    Int J Nanomedicine; 2019 Jan 01; 14():3557-3569. PubMed ID: 31190812
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Multifunctional aptamer-based nanoparticles for targeted drug delivery to circumvent cancer resistance.
    Liu J, Wei T, Zhao J, Huang Y, Deng H, Kumar A, Wang C, Liang Z, Ma X, Liang XJ.
    Biomaterials; 2016 Jun 01; 91():44-56. PubMed ID: 26994877
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Reversing of multidrug resistance breast cancer by co-delivery of P-gp siRNA and doxorubicin via folic acid-modified core-shell nanomicelles.
    Wu Y, Zhang Y, Zhang W, Sun C, Wu J, Tang J.
    Colloids Surf B Biointerfaces; 2016 Feb 01; 138():60-9. PubMed ID: 26655793
    [Abstract] [Full Text] [Related]

  • 15. Reduction/photo dual-responsive polymeric prodrug nanoparticles for programmed siRNA and doxorubicin delivery.
    Wu M, Li J, Lin X, Wei Z, Zhang D, Zhao B, Liu X, Liu J.
    Biomater Sci; 2018 May 29; 6(6):1457-1468. PubMed ID: 29770812
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Targeted VEGF-triggered release of an anti-cancer drug from aptamer-functionalized metal-organic framework nanoparticles.
    Chen WH, Yang Sung S, Fadeev M, Cecconello A, Nechushtai R, Willner I.
    Nanoscale; 2018 Mar 08; 10(10):4650-4657. PubMed ID: 29465130
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.